Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
veronica.veschi@uniroma1.it
Veronica Veschi
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
veronica.veschi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Neuroblastoma epigenetic landscape: drugging opportunities
Neuroblastoma discoveries and challenges
2024
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
STAR Protocol
2024
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
NATURE COMMUNICATIONS
2023
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment
FRONTIERS IN MOLECULAR MEDICINE
2023
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells
PROCEEDINGS IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE
2023
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
JOURNAL OF CLINICAL MEDICINE
2022
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy
BIOMOLECULES
2022
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51
ONCOGENE
2022
Cancer cell targeting by CAR-T cells: A matter of stemness
FRONTIERS IN MOLECULAR MEDICINE
2022
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells
CANCERS
2022
Targeting epigenetic alterations in cancer stem cells
FRONTIERS IN MOLECULAR MEDICINE
2022
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy
CANCERS
2021
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review
GENES
2021
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
FRONTIERS IN ONCOLOGY
2021
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
NATURE COMMUNICATIONS
2021
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
ISCIENCE
2021
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
GUT
2021
Targeting MYCN in Pediatric and Adult Cancers
FRONTIERS IN ONCOLOGY
2021
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
ONCOGENE
2020
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer
CELL STEM CELL
2020
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma